Prolific announces major new investments and partnerships with Nantworks and Zylidac Bio CDMO

The Medical News ·
Health & Medicine United Kingdom

On the heels of our exciting major investment and Nantworks partnership announcement last week, Prolific Machines is pleased to announce a great new partnership with Zylidac Bio, a fully integrated biologics CDMO located next door to us in San Francisco Bay Area, to scale up the production of Prolific's Optogentics-enabled cell lines for clinical and GMP manufacturing!

Read original article on The Medical News →

Related news